News

July 6, 2015July 6, 2015

Survey Results Urge FDA to Review Biosimilars for Rheumatoid Arthritis

News

The Coalition of State Rheumatology Organizations, the country’s authority on state rheumatology society activities, recently conducted a survey of registered rheumatologists. The survey results revealed that while most of them are eager ... Read more

July 1, 2015July 8, 2015

Study Suggests Inflammation Must Be Considered to Predict Mortality

News, rheumatoid arthritis

When patients with rheumatoid arthritis want to know their mortality risk, their clinicians must rely on models generated in studies that consider a wide range of risk factors. These models ... Read more

June 29, 2015June 29, 2015

Rheumatoid Arthritis Tofacitinib Restores Skin Color In Vitiligo Patient

News

Dermatologists at Yale School of Medicine recently discovered that a medication for Rheumatoid Arthritis (RA) was able to restore the skin color of a patient with vitiligo. The study was published ... Read more

June 26, 2015

Hospira Presents New Data at EULAR 2015 on Comparable Effectiveness and Safety of Inflectra in Rheumatic Diseases switched from Remicade

News

Hospira, Inc. a world leading company in biosimilars, recently announced its data from an independent study in which patients with rheumatic diseases had similar safety and clinical effectiveness after switching from Remicade to ... Read more

June 24, 2015June 24, 2015

Hepatitis B Vaccine Less Effective in Patients With Rheumatoid Arthritis

News

In a recent study published in the Annals of Rheumatic Diseases and presented during the Annual Meeting of the European League Against Rheumatism (EULAR 2015), a team of researchers found ... Read more

June 22, 2015June 23, 2015

Xencor Announces Complete Results Of Its XmAb5871 Program

News

Xencor, Inc. has recently announced the results from a Phase 1b/2a clinical of its XmAb5871 for patients with a diagnosis of rheumatoid arthritis (RA). XmAb5871 is a first-in-class monoclonal antibody that ... Read more

June 17, 2015June 17, 2015

Galapagos Announces Completion of DARWIN Studies Of Filgotinib in RA Patients

News

Galapagos NV a clinical stage Belgium-based biotech company, recently announced the last rheumatoid arthritis patients in its DARWIN 1 and 2 dose finding studies with filgotinib have completed their final visit. ... Read more

June 15, 2015June 15, 2015

Inflammatory Arthritis Patients Found to Adopt an Antalgic Gait

News

Researchers at the University of Auckland and Auckland University of Technology in New Zealand reported that patients with inflammatory arthritis, like rheumatoid arthritis, adopt a gait pattern that avoids pain ... Read more

June 11, 2015June 12, 2015

Biogen and Samsung Bioepis Develop Biosimilars for RA Treatment

News, rheumatoid arthritis

Biogen and Samsung Bioepis Co., Ltd. have three exciting new anti-tumor necrosis factor (anti-TNF) biosimilars under development to treat patients with rheumatoid arthritis. Representatives from the companies will present data at ... Read more

June 10, 2015June 10, 2015

Study Shows Patients With RA Experience Neuropathic Pain, Fibromyalgia and Migraines

News, rheumatoid arthritis

During the 70th Annual Meeting of The Canadian Rheumatology Association (CRA) held at the Fairmont Chateau Frontenac in Quebec, Canada on February 4–7, 2015, a team of researchers presented results ... Read more